SCI Foundation is now Unlimit Health. Learn more about what the change means for our ongoing efforts to eliminate neglected tropical diseases
We work across multiple sectors in numerous countries to deliver effective and robust health programmes that have a lasting impact. This includes support for partner governments to deliver tens of millions of deworming treatments every year, and to expand treatment programmes.
In our 20-year history we have supported the delivery of over 1 billion treatments for parasitic diseases.
Our vision is resilient systems that sustain good health, so everyone everywhere can reach their full potential.
Our mission is to share evidence and expertise to end preventable parasitic infections in affected communities.
We achieve this by working across multiple sectors in numerous countries to deliver effective and robust health programmes that have a lasting impact. Our work includes;
Find out more in our FAQ
Our strategy is aligned with the WHO NTD Roadmap 2021-2030 pillars of:
1. Accelerate programmatic action
2. Intensify cross-cutting approaches
3. Change operating models and culture to facilitate country ownership.
Each pillar has been tailored into a goal specific to our own vision and mission. As such, the strategy is also linked with several of the UN Sustainable Development Goals. Each strategic goal relates to one or more of the WHO health system building blocks, to ensure that our actions contribute to the achievement of our vision of resilient health systems.
Read the strategy
Lire la stratégie en français
Intensify cross cutting approaches to elimination and health systems strengthening
Accelerate programmatic action towards elimination of parasitic infections and health equity
Promote and enable country ownership and leadership of programmes for elimination of parasitic infections
To fulfil our mission, we work in partnership to develop country-owned solutions that eliminate parasitic infections, for good. Over the strategic period, this will involve delivering services under three key areas:
Building collaborative partnerships
Cross-sectoral health systems strengthening
Evidence-based disease support